Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Filings indexed 553 across all filing types
Latest filing 2022-08-17 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권) (2022.10)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement for Equity Securities) filed by HLB Co., Ltd. It includes a '정정신고' (Amendment) notice, detailed legal references regarding capital markets, and a comprehensive '핵심투자위험' (Key Investment Risks) section. This is a formal regulatory filing required for public offerings or capital changes, which falls under the category of Regulatory Filings (RNS) as it is a specific legal document submitted to the financial regulatory authority.
2022-08-17 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a decision on a paid-in capital increase (유상증자결정). It details the terms of the share issuance, including the number of shares, pricing methods, and allocation procedures. This falls under the category of announcements regarding new share issues or capital changes.
2022-08-16 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for HLB Co., Ltd. covering the period from January 1, 2022, to June 30, 2022. It contains detailed company information, business descriptions, financial data, and management reports, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean
증권신고서(지분증권) (2022.10)
Capital/Financing Update Classification · 1% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details a capital raise (specifically a rights offering/public offering of shares) and includes comprehensive 'Investment Risk Factors' (핵심투자위험), business descriptions, and financial disclosures required for regulatory approval of a securities issuance. This is a formal regulatory filing for capital raising, not an annual report or a simple announcement.
2022-08-16 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from HLB Co., Ltd. regarding a decision to issue new shares (유상증자결정). It details the capital increase, including the number of shares, pricing methods, and allocation procedures. This falls under the category of capital and financing updates, specifically related to share issuance and capital structure changes.
2022-08-12 Korean
지속가능경영보고서등관련사항(자율공시)
Report Publication Announcement Classification · 1% confidence The document is a short regulatory filing (voluntary disclosure) from HLB announcing the publication of their '2021 HLB ESG Report'. It provides metadata about the report (reporting period, standards used, verification body) and explicitly states at the end that the detailed information is in the attached report. Following the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2022-08-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.